Search clinical trials for: SB424323

Total 2 results

GlaxoSmithKline

Completed

Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke

Atrial Fibrillation | Fibrillation, Atrial

Spain, United States, Taiwan, Estonia, Canada, Sweden, Thailand, Germany, Korea, Republic of, Latvia, Romania, Argentina, Belgium, France, India, Netherlands, New Zealand, Italy, Norway, United Kingdom, Greece, Hungary, Denmark, Brazil, Mexic...
GlaxoSmithKline

Completed

ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST) (TEMPEST)

Arthroplasty

3

Subscribe